	Efficacy and safety of almonertinib as adjuvant therapy in stage II-IIIA EGFR-mutant non-small cell lung cancer: a retrospective study. Front Med (Lausanne) Cao T, Chen L, Li Y, Wu S, Liu Y, Tian W, Zhang Y, An Y, Wang M, Lu Z, Wang Q. PMID: 42625890 [PubMed]
	Implementation of a lung cancer screening program at an urban safety-net hospital: enabling solutions via stakeholder engagement. Front Public Health Kuperberg SJ, Mercado J. PMID: 42625749 [PubMed - indexed for MEDLINE]
	The relationship between sarcopenia detected in newly diagnosed lung cancer patients and serum levels of IL6, IGF-1 and myostatin. Front Aging Süzer K, Oflazoglu U, Demir L, Unal S, Guc ZG, Yildiz Y, Karalar FO, Kucukzeybek Y, Alacacioglu A. PMID: 42625663 [PubMed]
	An integrated multimodal model for early prediction of high-risk recurrence phenotype indicative of poor disease-free survival in stage IA NSCLC: a multicenter study. Front Immunol Lai L, Wang Y, Jiang J, Yang D, Wu J, Xie L, Wu J, Mao R, Zhang D, Wang X, Ming W, Tu J. PMID: 42625643 [PubMed - indexed for MEDLINE]
	Assessment of risk factors in persistent subsolid pulmonary nodules based on CT dynamic follow-up. BMC Med Imaging Li F, Liu J, Ren X, Chen Z, Yang S, Ma Y, Li Y, Du Y, Yang X. PMID: 42625155 [PubMed - indexed for MEDLINE]
	Diagnostic Performance of a Multiplex Circulating Tumor DNA Assay for Lung Cancer Detection. J Mol Diagn Hjorth-Hansen P, Jacobsen CM, Nederby L, Borg M, Hilberg O, Wen SWC, Timm S, Hansen TF, Andersen RF. PMID: 42624248 [PubMed - as supplied by publisher]
	Lung cancer mortality of workers occupationally exposed to titanium dioxide in Germany: new insights from a retrospective cohort study after accounting for smoking status. Int J Hyg Environ Health Jannis H, Hiltrud M, Ingo L, Maria B, Stefanie J K, Emilio G. PMID: 42624005 [PubMed - as supplied by publisher]
	Spatially Fractionated Induction Radiotherapy to Widen the Therapeutic Window in Locally Advanced Non-Small-Cell Lung Cancer (SPARROW): Study Protocol of a Multicenter, Randomized, Open-Label Seamless Phase I/II Trial. Clin Lung Cancer Regnery S, Ehle M, Neugebauer D, Gerke L, Schindehütte R, Bauer L, Mende S, Kirchner M, Balzer A, Gahlawat A, Abdollahi A, Kazdal D, Stenzinger A, Hörner-Rieber J, Uhl M, Aninditha K, Münter M, Welzel T, Debus J, Weykamp F. PMID: 42623891 [PubMed - as supplied by publisher]
	Association between rheumatoid arthritis-interstitial lung disease and lung cancer: a two -sample Mendelian randomization study with East Asian genetic instruments. Mod Rheumatol Hsu CH, Chen SC, Yu YL. PMID: 42623285 [PubMed - as supplied by publisher]
	Increasing lung cancer screening referral/order and completion rates in primary care through patient outreach and shared decision making. J Med Screen DiCarlo M, Shimada A, Sifri R, Johnson M, Keith SW, Zhan T, Jackson H, Indictor A, Burgess N, Mahon I, Pisano E, Myers RE. PMID: 42623060 [PubMed - as supplied by publisher]
	KRAS-Targeted Therapies in NSCLC: Resistance, Combination Strategies, and Emerging Clinical Paradigms. Med Oncol Kapoor A, Sansar B, Gupta A, Mishra BK, Rungta A, Pal A, Srivastava S, Shah M, Menon N, Pai T, Shetty O, Chandrani P, Choughule A, Noronha V, Prabhash K. PMID: 42622884 [PubMed - indexed for MEDLINE]
	Efficacy and safety of different treatment regimens in patients with small cell lung cancer progressing from limited-stage to extensive-stage disease. Ther Adv Med Oncol Yu M, Liu Y, Wang X, Cui W, Sun F, Li Y, Zhao K, Zhao H, Meng X. PMID: 42621307 [PubMed]
	Prospective subtyping identifies an association between high pretreatment levels of DEspR(+) neutrophil extracellular trap-forming neutrophils and microvesicles during sterile inflammation with poor survival in patients with metastatic non-small cell lung cancer receiving first-line combination chemo-immunotherapy. Front Immunol Herrera VLM, Mahdaviani K, Choi J, Chen SH, Gunn E, Stadnicki K, Mortazavi-Zadeh A, Lok JJ, Tapan U, Ruiz-Opazo N. PMID: 42620556 [PubMed - indexed for MEDLINE]
	Update 2026: Management of Small Cell Lung Cancer. Lung Lalla M, Dhillon P, Polat BE, Cheng H. PMID: 42618851 [PubMed - indexed for MEDLINE]
	Automated identification of interstitial lung abnormalities in lung screening using quantitative CT. BMJ Open Respir Res Logan N, Desai SR, Bartlett EC, Hewitt R, George PM, Devaraj A. PMID: 42618282 [PubMed - indexed for MEDLINE]
	Increasing uptake of lung cancer screening through a patient 'nudge': A randomized pragmatic trial. Am J Prev Med Carroll NM, Maclennan AJ, Wain KF, Hixon B, Steiner J, Ritzwoller DP. PMID: 42617889 [PubMed - as supplied by publisher]
	Gold Nanostars: Emerging Plasmonic Nanoplatforms for Lung Cancer Diagnosis and Therapy. Eur J Pharm Sci Rawat E, Ali AA, Kumar M, Uniyal P, Haswani NG, Bhongade BA, El-Tanani M, Thakkar V, Kapoor DU. PMID: 42617669 [PubMed - as supplied by publisher]
	What matters most early in the cancer trajectory: patient concerns and priorities in pancreatic and lung cancer (BetterEveryDay trial). Eur J Oncol Nurs Mikkelsen MK, Rolin L, Theile S, Markman MJN, Hald C, Chen IM. PMID: 42617508 [PubMed - as supplied by publisher]
	Experience of the implementation of a lung cancer screening program at the Hospital General de Catalunya (Barcelona, Spain). Curr Probl Cancer Moya-Horno I, González-Marrón A, Barcos-Muñoz P, Abad S, Molina-Vila MÁ, Torres-Martí A, González X, Mayolas N, Rosell R. PMID: 42617374 [PubMed - as supplied by publisher]
	Efficacy and prognostic analysis of induction chemoimmunotherapy in unresectable stage â…¢ non-small cell lung cancer: a single-center retrospective study. Lung Cancer Gan X, Yu Z, Zhang L, Xie W, Sun X, Li Y, Fang J, Li Y, Liu Y, Liu Z, Tang Y, Zhou C, Xie Z, Yao W, Ouyang S, Zhang J, Chen P, Wang H, Liu H. PMID: 42617307 [PubMed - as supplied by publisher]

Articles 1 - 20 / 162430

Page 1 of 8122



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy